INDIUM Drug Patent Profile
✉ Email this page to a colleague
When do Indium patents expire, and what generic alternatives are available?
Indium is a drug marketed by Curium, Bwxt Itg, Ge Healthcare, and Sun Pharm Inds Inc. and is included in four NDAs.
The generic ingredient in INDIUM is indium in-111 pentetreotide kit. There are twenty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the indium in-111 pentetreotide kit profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for INDIUM?
- What are the global sales for INDIUM?
- What is Average Wholesale Price for INDIUM?
Summary for INDIUM
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Drug Prices: | Drug price information for INDIUM |
| DailyMed Link: | INDIUM at DailyMed |
US Patents and Regulatory Information for INDIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Curium | INDIUM IN 111 CHLORIDE | indium in-111 chloride | INJECTABLE;INJECTION | 019841-001 | Sep 27, 1994 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharm Inds Inc | INDIUM IN-111 PENTETREOTIDE KIT | indium in-111 pentetreotide kit | INJECTABLE;INJECTION | 212785-001 | Jul 1, 2024 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bwxt Itg | INDIUM IN 111 OXYQUINOLINE | indium in-111 oxyquinoline | INJECTABLE;INJECTION | 202586-001 | Jul 25, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ge Healthcare | INDIUM IN 111 OXYQUINOLINE | indium in-111 oxyquinoline | INJECTABLE;INJECTION | 019044-001 | Dec 24, 1985 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
